Literature DB >> 11096741

Hypoxic-Ischemic Encephalopathy.

.   

Abstract

Hypoxic-ischemic encephalopathy (HIE) in neonates is often difficult to diagnose in "real time" at the bedside because of the variety of disorders that can cause neonatal seizures and other nonspecific signs of encephalopathy. Standard interventions to support respiratory and cardiovascular disorders associated with HIE are appropriate, but none has been demonstrated to alter neurologic outcome. Anticonvulsants are indicated when seizures are observed, although they are considered a sign of HIE rather than a cause of injury. There is overwhelming evidence that the excitotoxic cascade that evolves during HIE extends over several days after the insult and is modifiable. Clinical trials of potentially neuroprotective interventions such as hypothermia are under way.

Entities:  

Year:  2000        PMID: 11096741     DOI: 10.1007/s11940-000-0012-3

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  22 in total

1.  Antepartum risk factors for newborn encephalopathy: the Western Australian case-control study.

Authors:  N Badawi; J J Kurinczuk; J M Keogh; L M Alessandri; F O'Sullivan; P R Burton; P J Pemberton; F J Stanley
Journal:  BMJ       Date:  1998-12-05

2.  Hypothermia treatment and the newborn.

Authors:  J S Wyatt; M Thoresen
Journal:  Pediatrics       Date:  1997-12       Impact factor: 7.124

Review 3.  Interventions for perinatal hypoxic-ischemic encephalopathy.

Authors:  R C Vannucci; J M Perlman
Journal:  Pediatrics       Date:  1997-12       Impact factor: 7.124

4.  Effect of allopurinol on postasphyxial free radical formation, cerebral hemodynamics, and electrical brain activity.

Authors:  F Van Bel; M Shadid; R M Moison; C A Dorrepaal; J Fontijn; L Monteiro; M Van De Bor; H M Berger
Journal:  Pediatrics       Date:  1998-02       Impact factor: 7.124

5.  Low dose flunarizine protects the fetal brain from ischemic injury in sheep.

Authors:  R Berger; T Lehmann; J Karcher; Y Garnier; A Jensen
Journal:  Pediatr Res       Date:  1998-09       Impact factor: 3.756

6.  Use of barbiturate therapy in severe perinatal asphyxia: a randomized controlled trial.

Authors:  R N Goldberg; P Moscoso; C R Bauer; F L Bloom; R G Curless; B Burke; E Bancalari
Journal:  J Pediatr       Date:  1986-11       Impact factor: 4.406

7.  Abnormal magnetic resonance signal in the internal capsule predicts poor neurodevelopmental outcome in infants with hypoxic-ischemic encephalopathy.

Authors:  M A Rutherford; J M Pennock; S J Counsell; E Mercuri; F M Cowan; L M Dubowitz; A D Edwards
Journal:  Pediatrics       Date:  1998-08       Impact factor: 7.124

Review 8.  Hypoxic and ischemic central nervous system disorders in infants and children.

Authors:  M V Johnston; W H Trescher; G A Taylor
Journal:  Adv Pediatr       Date:  1995

9.  Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants?

Authors:  K B Nelson; J K Grether
Journal:  Pediatrics       Date:  1995-02       Impact factor: 7.124

10.  Persistent increases in cerebral lactate concentration after birth asphyxia.

Authors:  J D Hanrahan; I J Cox; A D Edwards; F M Cowan; J Sargentoni; J D Bell; D J Bryant; M A Rutherford; D Azzopardi
Journal:  Pediatr Res       Date:  1998-09       Impact factor: 3.756

View more
  1 in total

Review 1.  Current progress in the derivation and therapeutic application of neural stem cells.

Authors:  Yuewen Tang; Pei Yu; Lin Cheng
Journal:  Cell Death Dis       Date:  2017-10-12       Impact factor: 8.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.